Boston Scientific Corporation

Informe acción NYSE:BSX

Capitalización de mercado: US$133.3b

Salud financiera de hoja de balance de Boston Scientific

Salud financiera controles de criterios 5/6

Boston Scientific tiene un patrimonio de accionistas total de $21.0B y una deuda total de $10.9B, lo que sitúa su ratio deuda-patrimonio en 51.9%. Sus activos y pasivos totales son $38.1B y $17.1B respectivamente. El BAIT de Boston Scientific es de $2.8B, por lo que su ratio de cobertura de intereses es de 14.4. Tiene efectivo e inversiones a corto plazo que ascienden a $2.5B.

Información clave

51.9%

Ratio deuda-patrimonio

US$10.88b

Deuda

Ratio de cobertura de intereses14.4x
EfectivoUS$2.50b
PatrimonioUS$20.96b
Total pasivoUS$17.12b
Activos totalesUS$38.08b

Actualizaciones recientes sobre salud financiera

Recent updates

Why The Fundamentals Make Me Bullish On Boston Scientific

Oct 31

Boston Scientific Q3: Good Growth, But Not Good Enough To Justify Its P/E Ratio

Oct 23

Is Boston Scientific (NYSE:BSX) A Risky Investment?

Oct 10
Is Boston Scientific (NYSE:BSX) A Risky Investment?

Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement

Sep 24
Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement

Boston Scientific: Forward Returns Are Likely To Be Disappointing For Investors

Sep 20

Boston Scientific Corporation's (NYSE:BSX) P/E Still Appears To Be Reasonable

Sep 09
Boston Scientific Corporation's (NYSE:BSX) P/E Still Appears To Be Reasonable

A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX)

Aug 23
A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX)

The Strong Earnings Posted By Boston Scientific (NYSE:BSX) Are A Good Indication Of The Strength Of The Business

Aug 08
The Strong Earnings Posted By Boston Scientific (NYSE:BSX) Are A Good Indication Of The Strength Of The Business

Boston Scientific Q2 Earnings Preview: Can The Rally Continue?

Jul 17

Here's Why We Think Boston Scientific (NYSE:BSX) Is Well Worth Watching

Jul 05
Here's Why We Think Boston Scientific (NYSE:BSX) Is Well Worth Watching

Should You Investigate Boston Scientific Corporation (NYSE:BSX) At US$77.00?

Jun 21
Should You Investigate Boston Scientific Corporation (NYSE:BSX) At US$77.00?

Boston Scientific Has Become A Standout Growth Story In Med-Tech

Jun 13

Why We're Not Concerned About Boston Scientific Corporation's (NYSE:BSX) Share Price

Jun 08
Why We're Not Concerned About Boston Scientific Corporation's (NYSE:BSX) Share Price

Is Boston Scientific (NYSE:BSX) Using Too Much Debt?

May 10
Is Boston Scientific (NYSE:BSX) Using Too Much Debt?

Boston Scientific (NYSE:BSX) Is Reinvesting At Lower Rates Of Return

Apr 22
Boston Scientific (NYSE:BSX) Is Reinvesting At Lower Rates Of Return

Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash

Apr 05

A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX)

Mar 26
A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX)

We Ran A Stock Scan For Earnings Growth And Boston Scientific (NYSE:BSX) Passed With Ease

Feb 29
We Ran A Stock Scan For Earnings Growth And Boston Scientific (NYSE:BSX) Passed With Ease

What You Can Learn From Boston Scientific Corporation's (NYSE:BSX) P/E

Feb 15
What You Can Learn From Boston Scientific Corporation's (NYSE:BSX) P/E

Is Boston Scientific (NYSE:BSX) A Risky Investment?

Feb 02
Is Boston Scientific (NYSE:BSX) A Risky Investment?

Boston Scientific (NYSE:BSX) Could Be Struggling To Allocate Capital

Jan 19
Boston Scientific (NYSE:BSX) Could Be Struggling To Allocate Capital

Boston Scientific: Portfolio Updates Driving Top-Line Growth

Jan 17

Boston Scientific: Continued M&A Drives More Growth

Jan 10

Is Boston Scientific Corporation (NYSE:BSX) Worth US$56.1 Based On Its Intrinsic Value?

Dec 04
Is Boston Scientific Corporation (NYSE:BSX) Worth US$56.1 Based On Its Intrinsic Value?

Does Boston Scientific (NYSE:BSX) Have A Healthy Balance Sheet?

Nov 03
Does Boston Scientific (NYSE:BSX) Have A Healthy Balance Sheet?

Boston Scientific: Delivering Strong Growth, But Sector Derating Is A Big Issue

Oct 30

ADVENT Offers Up An Early Present For Boston Scientific Investors

Aug 28

Estimating The Fair Value Of Boston Scientific Corporation (NYSE:BSX)

Aug 24
Estimating The Fair Value Of Boston Scientific Corporation (NYSE:BSX)

Boston Scientific (NYSE:BSX) Seems To Use Debt Quite Sensibly

Jul 25
Boston Scientific (NYSE:BSX) Seems To Use Debt Quite Sensibly

Boston Scientific Remains Operationally Sound But May Have Limited Upside

Jul 14

Investors Could Be Concerned With Boston Scientific's (NYSE:BSX) Returns On Capital

Jul 10
Investors Could Be Concerned With Boston Scientific's (NYSE:BSX) Returns On Capital

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($8.8B) de BSX superan a sus pasivos a corto plazo ($5.9B).

Pasivo a largo plazo: Los activos a corto plazo ($8.8B) de BSX no cubren sus pasivos a largo plazo ($11.2B).


Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (40%) de BSX se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de BSX ha pasado de 112.2% a 51.9% en los últimos 5 años.

Cobertura de la deuda: La deuda de BSX está bien cubierta por el flujo de caja operativo (27%).

Cobertura de intereses: Los pagos de intereses de la deuda de BSX están bien cubiertos por el BAIT (14.4x cobertura).


Hoja de balance


Descubre empresas con salud financiera